Genomics

Dataset Information

0

Metabolic reprogramming drives pancreatic β cell neogenesis from α cells [ATAC-seq]


ABSTRACT: Loss of functional β cells is a hallmark of diabetes, and restoring β cell mass remains a critical goal in the quest for a specific therapy. One potential strategy is to convert non-β cells in the islet, such as α cells, into insulin-producing cells. Although several compounds have been identified to induce β cell-like features in α cells, none have yet been successfully translated into clinical applications. In this study, we identify PRC2 inhibitors as potent inducers of β cell-enriched gene expression in α cells, acting through modulation of the AR-ETV1 complex. AR inhibition suppresses glycogen synthesis and enhances the pentose phosphate pathway (PPP). Direct metabolic reprogramming with methyl esterified 6-phosphogluconate (ME-6-PG), an intermediate metabolite of the PPP, induces β cell-like features in α cells, stimulate β cell regeneration and ameliorates diabetes. Our findings demonstrate that metabolic reprogramming can drive β cell regeneration and highlight a promising therapeutic strategy for diabetes.

ORGANISM(S): Mus musculus

PROVIDER: GSE302785 | GEO | 2026/06/18

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2026-06-18 | GSE302786 | GEO
2026-06-18 | GSE302787 | GEO
2026-06-18 | GSE302889 | GEO
2013-02-13 | E-GEOD-42223 | biostudies-arrayexpress
2020-10-16 | GSE152751 | GEO
2020-10-01 | GSE151338 | GEO
2023-09-18 | GSE208002 | GEO
2013-02-13 | GSE42223 | GEO
2012-07-31 | E-GEOD-38933 | biostudies-arrayexpress
2023-03-10 | PXD028314 | Pride